Navigation Links
Otonomy Introduces Scientific Advisory Board
Date:3/30/2009

survival and neurite extension in cochlear neurons, as well as the biology of middle ear inflammation, tissue growth and recovery during otitis media. Dr. Ryan completed postdoctoral training at Northwestern University after receiving a joint Ph.D. in physiology/biophysics and psychology from the University of Washington. Dr. Ryan is a past president of the Association for Research in Otolaryngology and a member of the Advisory Council for the National Institute on Deafness and Other Communication Disorders at the NIH, the Tinnitus Research Consortium and the Council of Scientific Trustees of the Deafness Research Foundation. He is a member of the Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum and chairs the Jury for this international otolaryngology research society.

Stefan Heller, Ph.D.

Dr. Heller is associate professor in the departments of Otolaryngology - Head & Neck Surgery and Molecular & Cellular Physiology at Stanford University School of Medicine. He is an associate member of the Stanford Institute for Stem Cell Biology and Regenerative Medicine and an affiliate of the Stanford Center on Longevity. Dr. Heller is researching the molecular basis of hearing and balance as well as developing therapies to reverse sensory hair cell loss in the cochlea. He joined the faculty of Harvard Medical School after completing his postdoctoral work in sensory neuroscience at The Rockefeller University. Dr. Heller earned a Ph.D. from Johannes Gutenberg University and conducted doctoral research at the Max-Planck Institute for Brain Research.

Charles Liberman, Ph.D.

Dr. Liberman is the Schuknecht Professor of Otology and Laryngology at Harvard Medical School and the director of the Eaton-Peabody Laboratory at Massachusetts Eye and Ear Infirmary, one of the largest laboratories in the world devoted to the study of hearing and deafne
'/>"/>

SOURCE Otonomy Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Celsis Introduces ReACT(TM) RNA-Based Microbial Detection Assays
2. PHARMORX Security Introduces New Technology Solutions for Counterfeiting, Grey Market Diversion, Track & Trace
3. DNA2.0 Introduces Freedom of Expression With a New Family of Bacterial Expression Vect:ors
4. Lumenis(R) Introduces Cost-Saving Innovations at the 2009 American Academy of Dermatology (AAD) Annual Meeting
5. GeneCopoeia Introduces Genome-Wide MicroRNA (miRNA) Functional Analysis Tools
6. Video: Schering-Plough Introduces AFRIN(R) PureSea(TM): A Natural, Gentle Nasal Rinse From the Seas of Northern France
7. Sigma-Aldrich Introduces MISSION(R) LentiPlex(TM) Pooled shRNA Libraries to Enable Rapid Whole Genome Screening in Primary Cells, Stem Cells or Tumor Cells
8. MaxCyte Introduces the GT(TM) Flow Transfection System for Application with Autologous and Allogeneic Stem Cell Therapies
9. Max Muscle Introduces First-Ever Probiotics Protein Bar
10. bioMerieux Introduces Surveillance Tool to Fight Healthcare-Associated Infections
11. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... NORTH CHICAGO, Ill. , May 26, 2015 ... biopharmaceutical company, announced today that it has completed ... and commercial presence in oncology. Pharmacyclics is a ... (ibrutinib), a first-in-class BTK-inhibitor used to treat hematological ... "The companies, shared expertise, combined with AbbVie,s broad ...
(Date:5/25/2015)... 2015  PureTech, a science-driven healthcare company seeking to ... ways, announced today that Dame Marjorie Scardino , ... Pearson, has been appointed to PureTech,s Board of Directors ... current Board member Joi Ito , MIT Media ... Ben Shapiro , PureTech,s outgoing Chairman and co-founder, former ...
(Date:5/22/2015)... DUBLIN , May 22, 2015  Actavis plc ... of the U.S. Court of Appeals for the Second ... 2014 preliminary injunction requiring the Company to continue distribution ... Logo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO   ... uphold this ruling, we intend to continue our strong ...
(Date:5/22/2015)... DALLAS , May 22, 2015 Baylor ... and the Translational Genomics Research Institute (TGen) in ... that will focus on accelerating early detection and treatments for ... science of both institutions will lead to new clinical trials ... therapies – bridging the gap from bench to bedside across ...
Breaking Biology Technology:AbbVie Completes Acquisition of Pharmacyclics 2AbbVie Completes Acquisition of Pharmacyclics 3AbbVie Completes Acquisition of Pharmacyclics 4AbbVie Completes Acquisition of Pharmacyclics 5AbbVie Completes Acquisition of Pharmacyclics 6PureTech Adds Dame Marjorie Scardino to Board of Directors, Names Joi Ito as Chairman of the Board and Expands Management Team 2PureTech Adds Dame Marjorie Scardino to Board of Directors, Names Joi Ito as Chairman of the Board and Expands Management Team 3Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 2Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 3Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 4Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 5Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 6Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 7Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 8Precision Medicine Collaboration to Increase Options for Cancer Patients 2Precision Medicine Collaboration to Increase Options for Cancer Patients 3Precision Medicine Collaboration to Increase Options for Cancer Patients 4
... on InterMune Phase 3 CAPACITY Program - ... patient retention rate in CAPACITY -, BRISBANE, Calif., Oct. ... on October 16, 2008, the Japanese,Ministry of Health, Labor and ... & Co. Ltd. to market pirfenidone,for the treatment of patients ...
... million to create a leading center for medical excellence; ... ... Fueled by a grant from the John S.,and James L. Knight ... the BioInnovation Institute in,Akron -- a unique collaboration that will expand ...
... ISTO Technologies, Inc., a privately,held orthobiologics company, ... injectable cell-based therapy for spinal disc,repair. The data ... Annual,Meeting of the North American Spine Society. Studies ... (UCSF) Department of Orthopedics,were designed to investigate potential ...
Cached Biology Technology:InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF 2InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF 3InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF 4BioInnovation Institute in Akron Launched 2BioInnovation Institute in Akron Launched 3BioInnovation Institute in Akron Launched 4Positive Preclinical Data on Cell Therapy for Spinal Disc Repair Presented at 23rd Annual Meeting of the North American Spine Society 2
(Date:5/14/2015)... 14, 2015 Research and Markets ( ... "Fingerprint Sensors Market in Smart Mobile Devices " ... that 2014 was a watershed year for fingerprint sensors ... ,Apple Pay,. Apple gave fingerprint sensors a raison d,etre ... Fingerprint sensors are a must-have feature in flagship smartphones. ...
(Date:5/11/2015)... SAN JOSE, Calif. , May 11, 2015 ... leading developer of human interface solutions, today announced ... Senior Vice President and Chief Financial Officer, reporting ... Mr. Ali replaces Synaptics, current Chief Financial Officer, ... in December 2014. Mr. Ali ...
(Date:5/11/2015)... RYE, N.Y. , May 11, 2015 ... company, announced the start of a new Phase III ... effect of its novel formulation, CM-AT, on all children ... results of its FDA Phase III double blinded clinical ... who had low levels of the digestive enzyme chymotrypsin. ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... and Prevention (CDC) today released new infection control ... Carbapenemase (KPC)-Producing Organisms, one of the ... shown that infections with these highly resistant bacteria ... In Guidance for Control of Infections with ...
... in German . The gene Myc is ... division. It causes the production of a protein which, as ... % of all human genes. When this gene mutates to ... Thereby the gene plays a decisive role in the development ...
... 18, 2009) Epidemiologists and computer scientists at the ... low-cost, green technology for automatically tracking the use of ... they exit patient rooms. This novel method of ... control in hospitals, was released today at the annual ...
Cached Biology News:Press statement on new CDC MMWR on Klebseilla pneumonia Carbapenemase-producing organisms 2Pilot study shows effectiveness of new, low-cost method for monitoring hand hygiene compliance 2
...
Mouse polyclonal antibody to QDPR - quinoid dihydropteridine reductase...
... The F10 tubing kit provides high-pressure ... DuoFlow system and other chromatography systems. ... Teflon, Tefzel, and orange PEEK tubing ... DuoFlow basic chromatography system running at ...
PTC-100 cycler with gold/silver block with Hot Bonnet heated lid, holds one 96-well V-plate or96x0.2ml tubes...
Biology Products: